Justice Department, Drug Enforcement Administration Briefing — April 1, 2026
Estimated reading time: 5 minutes
1. Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017
Sub: Justice Department, Drug Enforcement Administration
2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Title-Voice of Customer Survey
Sub: Justice Department
Content: The Federal Bureau of Investigation, Office of Private Sector, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
3. Importer of Controlled Substances Application: Research Triangle Institute
Sub: Justice Department, Drug Enforcement Administration
Content: Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
4. Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Sub: Justice Department, Drug Enforcement Administration
Content: Pharmaron Manufacturing Services (US) LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
5. Importer of Controlled Substances Application: Sterling Wisconsin, LLC
Sub: Justice Department, Drug Enforcement Administration
Content: Sterling Wisconsin, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
6. Importer of Controlled Substances Application: Indivior Manufacturing LLC
Sub: Justice Department, Drug Enforcement Administration
Content: Indivior Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
7. Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (Document 2026-06258)
Sub: Justice Department, Drug Enforcement Administration
Content: Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
8. Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (Document 2026-06257)
Sub: Justice Department, Drug Enforcement Administration
Content: Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
9. Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Sub: Justice Department, Drug Enforcement Administration
Content: Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
